PharmaTox
The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
News
-
Epigenetics
Feb. 12, 2019 10:44 AM
Read an interview with Ragnhild Eskeland about her research on Epigenetics.
-
PharmaTox member awarded travel grants
Jan. 10, 2019 11:43 AM
PharmaTox Postdoc Mussie Ghezu Hadera have been awarded three travel grants. Congratulations!
-
Wonderful news – PharmaTox 2.0 funded!
Dec. 18, 2018 2:10 PM
-
Prof. Nordeng appointed by European Commission as independent scientific expert in PRAC
Dec. 4, 2018 1:55 PM
The Pharmacovigilance Risk Assessment Committee (PRAC) is the European Medicines Agency's (EMA) committee responsible for assessing and monitoring the safety of human medicines.
-
Successful UiO:LifeScience projects in PharmaTox!
Nov. 23, 2018 12:03 PM
